Cvrx Inc (CVRX) Stock Price, Quote & News

Company Profile

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular sy...

Industry: Medical Devices

Sector: Healthcare

Phone: 763 416 2840

Fax: 763 416 2841

Website: www.cvrx.com

Address:

9201 West Broadway Avenue, Suite 650, Minneapolis, United States

Spanish_guy Aug. 8 at 4:05 AM

$CVRX so are you telling me that for lowered guidance 8M revenue for a year, this drop 60% . Oh boy this IS a huge overreaction. Like fda didnt approval the product.

0 · Reply

JOHNNY_DANGER Aug. 7 at 11:17 PM

$CVRX Will they announce a 10 million dollar share repurchase program monday or tell us about a buyout offer they recieved ?

1 · Reply

Mendoza_333 Aug. 7 at 11:11 PM

$CVRX makes sense to get in - but distribution flow and oi are not as bullish as could be - maybe will flash flush before run up.

2 · Reply

ShowMeThaMonay Aug. 7 at 10:58 PM

$CVRX this a buy here?

1 · Reply

BuyOnRedSellOnGreen Aug. 7 at 10:55 PM

$CVRX they're hiring because things are so terrible. Read the conference call and look at the guidance management has laid out for the rest of the year. This is dead money.

0 · Reply

Gmblr777 Aug. 7 at 9:25 PM

$CVRX bought too early with average 2.75 :(

0 · Reply

JOHNNY_DANGER Aug. 7 at 9:16 PM

$CVRX I wouldn't be surprised if we see a filing from Bill Ackman that he took a stake.

1 · Reply

JOHNNY_DANGER Aug. 7 at 9:10 PM

$CVRX with average volume only around 300k shorts are gonna be in deep do do and racing to cover per the Johnny Danger Institute of Trade.

0 · Reply

theSnip3r Aug. 7 at 8:48 PM

$CVRX whats everyone avg here ????

2 · Reply

JOHNNY_DANGER Aug. 7 at 8:43 PM

$CVRX Opens over 3.50 monday and than the buyout rumors start.

0 · Reply

CVRx, Inc. (CVRX) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel Following Revenue Guidance Cut and Sales-Execution Disclosures

2026-08-07T12:11:51.000Z - 16 hours ago

CVRx downgraded to Hold from Buy at Lake Street

2026-08-07T11:31:09.000Z - 16 hours ago

CVRx downgraded to Hold from Buy at Craig-Hallum

2026-08-07T11:27:07.000Z - 16 hours ago

CVRx price target lowered to $5 from $10 at Canaccord

2026-08-07T08:45:31.000Z - 19 hours ago

CVRx downgraded to Neutral from Overweight at Piper Sandler

Aug 6, 2026, 4:30 PM EDT - 1 day ago

CVRx, Inc. Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 1 day ago

CVRx, Inc. Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 1 day ago

CVRx, Inc. Quarterly report: Q2 2026

Aug 6, 2026, 4:05 PM EDT - 1 day ago

CVRx Reports Second Quarter 2026 Financial and Operating Results

Jul 28, 2026, 8:30 AM EDT - 10 days ago

CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference

Jul 23, 2026, 4:30 PM EDT - 15 days ago

CVRx to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call on August 6, 2026

Jun 10, 2026, 8:00 AM EDT - 2 months ago

CVRx, Inc. Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

2026-06-09T11:41:42.000Z - 2 months ago

CVRx CFO Jared Oasheim to step down

Jun 9, 2026, 7:30 AM EDT - 2 months ago

CVRx Announces Chief Financial Officer Transition

Jun 2, 2026, 11:40 AM EDT - 2 months ago

CVRx, Inc. Transcript: 46th Annual William Blair Growth Stock Conference

Jun 2, 2026, 11:40 AM EDT - 2 months ago

CVRx, Inc. Slides: 46th Annual William Blair Growth Stock Conference

Jun 1, 2026, 11:00 AM EDT - 2 months ago

CVRx, Inc. Transcript: AGM 2026

May 27, 2026, 4:30 PM EDT - 2 months ago

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

May 20, 2026, 4:30 PM EDT - 2 months ago

CVRx to Present at the William Blair 46th Annual Growth Stock Conference

2026-05-14T14:43:59.000Z - 3 months ago

CVRx announces Humana Medicare Advantage coverage policy for Barostim therapy

HUM

May 14, 2026, 8:00 AM EDT - 3 months ago

CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy

May 11, 2026, 4:30 PM EDT - 3 months ago

CVRx, Inc. Earnings Call Transcript: Q1 2026

May 11, 2026, 4:30 PM EDT - 3 months ago

CVRx, Inc. Earnings release: Q1 2026

May 11, 2026, 4:30 PM EDT - 3 months ago

CVRx, Inc. Quarterly report: Q1 2026

May 11, 2026, 4:05 PM EDT - 3 months ago

CVRx Reports First Quarter 2026 Financial and Operating Results

2026-05-04T21:15:14.000Z - 3 months ago

CVRx enrolls first patient in BENEFIT-HF trial

May 4, 2026, 4:30 PM EDT - 3 months ago

CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

Apr 27, 2026, 4:30 PM EDT - 3 months ago

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

Apr 20, 2026, 4:30 PM EDT - 3 months ago

CVRx Announces Nomination of Michael Dale for Election to the Board of Directors

Apr 20, 2026, 8:00 AM EDT - 3 months ago

CVRx, Inc. Proxy statement: Proxy filing

Apr 20, 2026, 8:00 AM EDT - 3 months ago

CVRx, Inc. Proxy statement: Proxy filing

Apr 9, 2026, 9:00 AM EDT - 4 months ago

CVRx, Inc. Investigated by the Portnoy Law Firm

Mar 2, 2026, 8:30 AM EST - 5 months ago

CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting

2026-02-13T12:10:44.000Z - 6 months ago

CVRx price target lowered to $6 from $7 at JPMorgan

2026-02-13T11:55:30.000Z - 6 months ago

CVRx price target lowered to $10 from $11 at Canaccord

Feb 12, 2026, 4:30 PM EST - 6 months ago

CVRx, Inc. Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

CVRx, Inc. Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

CVRx, Inc. Earnings release: Q4 2025

Jan 29, 2026, 4:10 PM EST - 6 months ago

CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026

2026-01-22T21:20:25.000Z - 7 months ago

CVRx initiates BENEFIT-HF clinical trial

Jan 22, 2026, 4:05 PM EST - 7 months ago

CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

Jan 14, 2026, 6:45 PM EST - 7 months ago

CVRx, Inc. Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 7 months ago

CVRx, Inc. Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 8:00 AM EST - 7 months ago

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance

Jan 6, 2026, 8:30 AM EST - 7 months ago

CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy

Dec 22, 2025, 8:30 AM EST - 8 months ago

CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 3, 2025, 2:00 PM EST - 8 months ago

CVRx, Inc. Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 19, 2025, 8:30 AM EST - 9 months ago

CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 3:00 AM EST - 9 months ago

CVRx, Inc. Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 3:00 AM EST - 9 months ago

CVRx, Inc. Slides: FY 2025

Nov 6, 2025, 7:00 AM EST - 9 months ago

CVRx, Inc. Registration statement: Registration Filing

Nov 5, 2025, 4:30 PM EST - 9 months ago

CVRx, Inc. Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 9 months ago

CVRx, Inc. Quarterly report: Q3 2025

Nov 5, 2025, 4:30 PM EST - 9 months ago

CVRx, Inc. Earnings release: Q3 2025

Oct 22, 2025, 4:30 PM EDT - 10 months ago

CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025

Aug 12, 2025, 3:00 PM EDT - 1 year ago

CVRx, Inc. Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 12, 2025, 3:00 PM EDT - 1 year ago

CVRx, Inc. Slides: Canaccord Genuity’s 45th Annual Growth Conference

Aug 4, 2025, 4:30 PM EDT - 1 year ago

CVRx, Inc. Earnings Call Transcript: Q2 2025

Aug 4, 2025, 4:30 PM EDT - 1 year ago

CVRx, Inc. Quarterly report: Q2 2025

Aug 4, 2025, 4:30 PM EDT - 1 year ago

CVRx, Inc. Earnings release: Q2 2025

Aug 4, 2025, 4:05 PM EDT - 1 year ago

CVRx Reports Second Quarter 2025 Financial and Operating Results

Jul 29, 2025, 8:30 AM EDT - 1 year ago

CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 16, 2025, 7:30 AM EDT - 1 year ago

CVRx Announces Positive News on Outpatient Payment for Barostim

Jun 4, 2025, 11:00 AM EDT - 1 year ago

CVRx, Inc. Transcript: 45th Annual William Blair Growth Stock Conference

Jun 4, 2025, 11:00 AM EDT - 1 year ago

CVRx, Inc. Slides: 45th Annual William Blair Growth Stock Conference

May 28, 2025, 4:30 PM EDT - 1 year ago

CVRx to Present at the William Blair 45th Annual Growth Stock Conference

May 8, 2025, 4:30 PM EDT - 1 year ago

CVRx, Inc. Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

CVRx, Inc. Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

CVRx, Inc. Earnings release: Q1 2025

Apr 24, 2025, 4:30 PM EDT - 1 year ago

CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025

Apr 23, 2025, 8:00 AM EDT - 1 year ago

CVRx, Inc. Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

CVRx, Inc. Proxy statement: Proxy Filing

Apr 7, 2025, 4:05 PM EDT - 1 year ago

CVRx Reports Preliminary First Quarter 2025 Financial Results

Feb 12, 2025, 2:45 PM EST - 1 year ago

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim

Feb 4, 2025, 4:30 PM EST - 1 year ago

CVRx, Inc. Earnings Call Transcript: Q4 2024

Feb 4, 2025, 4:30 PM EST - 1 year ago

CVRx, Inc. Annual report: Q4 2024

Feb 4, 2025, 4:30 PM EST - 1 year ago

CVRx, Inc. Earnings release: Q4 2024

Feb 4, 2025, 4:05 PM EST - 1 year ago

CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Jan 21, 2025, 4:30 PM EST - 1 year ago

CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025

Jan 15, 2025, 5:15 PM EST - 1 year ago

CVRx, Inc. Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 5:15 PM EST - 1 year ago

CVRx, Inc. Slides: FY 2025

Dec 23, 2024, 4:30 PM EST - 1 year ago

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 4, 2024, 3:30 PM EST - 1 year ago

CVRx, Inc. Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:30 PM EST - 1 year ago

CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference

Oct 29, 2024, 4:30 PM EDT - 1 year ago

CVRx, Inc. Earnings Call Transcript: Q3 2024

Oct 29, 2024, 4:30 PM EDT - 1 year ago

CVRx, Inc. Quarterly report: Q3 2024

Oct 29, 2024, 4:30 PM EDT - 1 year ago

CVRx, Inc. Earnings release: Q3 2024

Oct 18, 2024, 2:08 PM EDT - 1 year ago

CVRx announces new CPT® Category I codes for Barostim

Oct 15, 2024, 4:30 PM EDT - 1 year ago

CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024

Sep 3, 2024, 8:30 AM EDT - 2 years ago

CVRx Announces Appointment of Two New Board Members

Spanish_guy Aug. 8 at 4:05 AM

$CVRX so are you telling me that for lowered guidance 8M revenue for a year, this drop 60% . Oh boy this IS a huge overreaction. Like fda didnt approval the product.

0 · Reply

JOHNNY_DANGER Aug. 7 at 11:17 PM

$CVRX Will they announce a 10 million dollar share repurchase program monday or tell us about a buyout offer they recieved ?

1 · Reply

Mendoza_333 Aug. 7 at 11:11 PM

$CVRX makes sense to get in - but distribution flow and oi are not as bullish as could be - maybe will flash flush before run up.

2 · Reply

ShowMeThaMonay Aug. 7 at 10:58 PM

$CVRX this a buy here?

1 · Reply

BuyOnRedSellOnGreen Aug. 7 at 10:55 PM

$CVRX they're hiring because things are so terrible. Read the conference call and look at the guidance management has laid out for the rest of the year. This is dead money.

0 · Reply

Gmblr777 Aug. 7 at 9:25 PM

$CVRX bought too early with average 2.75 :(

0 · Reply

JOHNNY_DANGER Aug. 7 at 9:16 PM

$CVRX I wouldn't be surprised if we see a filing from Bill Ackman that he took a stake.

1 · Reply

JOHNNY_DANGER Aug. 7 at 9:10 PM

$CVRX with average volume only around 300k shorts are gonna be in deep do do and racing to cover per the Johnny Danger Institute of Trade.

0 · Reply

theSnip3r Aug. 7 at 8:48 PM

$CVRX whats everyone avg here ????

2 · Reply

JOHNNY_DANGER Aug. 7 at 8:43 PM

$CVRX Opens over 3.50 monday and than the buyout rumors start.

0 · Reply

Spanish_guy Aug. 7 at 8:39 PM

$CVRX i have read again earnings. Its totally overreaction. Business IS on charge, revenue IS 60M anual, and they are opening new centers. Cash on hand IS good , and they have a credit line too for survive at least 7-8Q more.

0 · Reply

theSnip3r Aug. 7 at 8:36 PM

$CVRX loaded the boat 🚢 😎

1 · Reply

elmono Aug. 7 at 8:06 PM

$CVRX heavily shorted with no covering yet and cannacord conf next week….explosive

1 · Reply

Spanish_guy Aug. 7 at 8:04 PM

$CVRX 50%+ company traded today.

0 · Reply

Spanish_guy Aug. 7 at 7:20 PM

$CVRX they left holding the bag all the gamblers that bought at 3 or close. Just wow.

0 · Reply

Merkel Aug. 7 at 6:55 PM

$CVRX Next Runner CHR Revenue: $120M Cash: $200M Profit: $20M Current Marketcap: $3.5M Share price: $1,86

0 · Reply

MSG8898 Aug. 7 at 6:52 PM

$CVRX why would it rebound?

2 · Reply

MITornado Aug. 7 at 6:45 PM

$CVRX Yo Kevin, gonna need you to pull out your checkbook.

0 · Reply

lecorb Aug. 7 at 6:40 PM

$PN $CVRX $SEZL $FCUV $YXT BIG CRABS!

0 · Reply

MedDevice Aug. 7 at 6:34 PM

$CVRX State Humana MA Market Share (approx.) Estimated Total HF Adults (rough) Current Indicated TAM (~5.1% of HF) Expanded TAM if BENEFIT-HF succeeds (~14.6% of HF). TAM from comments at Goldman Sachs Healthcare Conference. Looks like a lot of TAM in Humana heavy states.

0 · Reply

Spanish_guy Aug. 7 at 6:32 PM

$CVRX Who IS selling at this prices? IS a normal reaction on this stock?

0 · Reply

JOHNNY_DANGER Aug. 7 at 6:13 PM

$CVRX JnJ is goi g to buy this company on the cheap.....5.00 is my guess.....offer probably on the desk of the ceo already.

0 · Reply

Market Cap	157.62M
Revenue (ttm)	56.65M
Net Income (ttm)	-53.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-94.10%
Debt to Equity Ratio	2.01

Volume	14,757,700
Avg Vol	564,628
Day's Range	N/A - N/A
Shares Out	26.54M
Stochastic %K	2%
Beta	0.81
Analysts	Strong Sell
Price Target	$11.17